본문 바로가기
KERD
논문KCI 등재

삽입형 제세동기 및 심장재동기화 치료

Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy

박형섭
대한내과학회 (The Korean Association Of Internal Medicine)|2016.03|대한내과학회지 (The Korean Journal of Medicine)|제90권 제3호|pp. 210-216

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

심부전Heart failureImplantableDefibrillators삽입형 제세동기Cardiac resynchronization therapy심장재동기화 치료
주제분류내과학

초록

심실세동 등에 의한 심정지가 있었거나 구조적인 심장질환에 동반된 심실빈맥이 있는 환자는 이후 돌연사가 발생할 가능성이 높은 것으로 알려져 있으며 이들에게 항부정맥제 치료만으로는 예방 효과가 부족하여 삽입형 제세동기(implantable cardioverter-defibrillator, ICD)를 삽입하는 것이 권고되고 있다[1]. 이러한 이차적 예방을 위한 ICD 삽입 외에 최근에는 심기능이 저하된 심부전 환자에서의 일차적 예방을 위한 ICD 삽입도 증가하고 있다. 이외에 적절한 약물 치료에도 불구하고 심부전증상이 지속되는 환자들을 대상으로 하여 심기능과 생존율을 증가시키기 위해 시행하는 심장재동기화 치료(cardiac resynchronization therapy, CRT) 또한 최근 활발히 시행되고 있다.

Abstract

The use of an implantable cardioverter-defibrillator (ICD) is an effective treatment strategy for patients with aborted sudden cardiac death (SCD) and ventricular tachyarrhythmias. Primary prevention of SCD is a strategy involving the use of ICDs in patients who are at high risk for but who have not had any previous events of ventricular arrhythmias or cardiac arrest. Cardiac resynchronization therapy (CRT) improves symptoms of heart failure and left ventricular systolic function when used in patients with severe heart failure symptoms, reduced left ventricular ejection, and a wide QRS complex. CRT has also been proven to reduce the rate of hospitalization due to heart failure as well as the rate of death from any cause. In this review, we discuss the clinical trials and current clinical indications for the ICD and CRT.

참고문헌 (23)

  1. European Heart Rhythm Association; Heart Rhythm Society, "ACC", AHA, American Heart Association Task Force and the European Society of Cardiology Committee for practice guidelines(writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death), pp.J Am Coll Cardiol, 2006[DOI]
  2. "A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) investigators", N Engl J Med, 337, pp.1576~1583 (1997)
  3. Cappato R, "Secondary prevention of sudden death : the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study", Am J Cardiol, 83, pp.68~73 (1999)
  4. Kuck KH, "Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg(CASH)", Circulation, 102, pp.748~754 (2000)
  5. Connolly SJ, "Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study", Eur Heart J, 21, pp.2071~2078 (2000)
  6. Epstein AE, "2012 ACCF", AHA, AHA, pp.HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities : a report of the American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[DOI]
  7. Moss AJ, "Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators", N Engl J Med, 335, pp.1933~1940 (1996)
  8. Buxton AE, "A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators", N Engl J Med, 341, pp.1882~1890 (1999)
  9. Moss AJ, "Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction", N Engl J Med, 346, pp.877~883 (2002)
  10. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
  11. Kadish A, "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy", N Engl J Med, 350, pp.2151~2158 (2004)
  12. Desai AS, "Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy : a meta-analysis of randomized controlled trials", JAMA, 292, pp.2874~2879 (2004)
  13. Lambiase PD, "Worldwide experience with a totally subcutaneous implantable defibrillator : early results from the EFFORTLESS S-ICD Registry", Eur Heart J, 35, pp.1657~1665 (2014)
  14. Kashani A, "Significance of QRS complex duration in patients with heart failure", J Am Coll Cardiol, 46, pp.2183~2192 (2005)
  15. Bleeker GB, "Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure", J Cardiovasc Electrophysiol, 15, pp.544~549 (2004)
  16. Bradley DJ, "Cardiac resynchronization and death from progressive heart failure : a meta-analysis of randomized controlled trials", JAMA, 289, pp.730~740 (2003)
  17. Bristow MR, "Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure", N Engl J Med, 350, pp.2140~2150 (2004)
  18. Cleland JGF, "The effect of cardiac resynchronization on morbidity and mortality in heart failure", N Engl J Med, 352, pp.1539~1549 (2005)
  19. Abraham WT, "Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure", Circulation, 110, pp.2864~2868 (2004)
  20. Linde C, "Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms", J Am Coll Cardiol, 52, pp.1834~1843 (2008)
  21. Moss AJ, "Cardiac-resynchronization therapy for the prevention of heart-failure events", N Engl J Med, 361, pp.1329~1338 (2009)
  22. Tang AS, "Cardiac-resynchronization therapy for mild-to-moderate heart failure", N Engl J Med, 363, pp.2385~2395 (2010)
  23. McAlister FA, "Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction : a systematic review", JAMA, 297, pp.2502~2514 (2007)

관련 논문AI추천

심장재동시화치료김형준, 신동구영남대학교 의과대학 · Journal of Yeungnam Medical Science2005 · 제22권 제2호Long-Term Prognosis of Patients with an Implantable Cardioverter-Defibrillator in Korea강석민, 김인철, 김태훈, 박영아, 박희남, 신동금, 양필성, 엄재선, 유희태, 이문형, 임영민, 정보영연세대학교의과대학 · Yonsei Medical Journal2017 · 제58권 제3호Implantable Cardioverter-Defibrillator of Korean Patients in a Single Center Registry곽혜빈, 김준수, 박경민, 박승정, 온영근, 황진경대한부정맥학회 · International Journal of Arrhythmia2017 · 제18권 제4호비허혈성 심근병증에서 심장돌연사의 일차적 예방을 위한 삽입형 제세동기김미나, 박성미대한내과학회 · 대한내과학회지2017 · 제92권 제1호비동시성 심실수축 및 심장 재동기화 치료조구영한국심초음파학회 · Journal of Cardiovascular Imaging2003 · 제11권 제2호삽입형 심실제세동기를 삽입한 환자들의 임상적 특징김유호, 김정욱, 김형용, 남기병, 박경민, 최기준, 홍윤기대한내과학회 · 대한내과학회지2008 · 제74권 제1호

이 간행물의 다른 논문 (8건)

심방세동의 항응고 치료 가이드라인정병천pp. 189-197관상동맥조영술 후 발생한 동정맥루 1예김영일, 임영효, 강민구, 문인태, 이동훈, 이지영, 이형탁pp. 231-233보존적 치료로 호전된 단일 대각지 폐색 심근경색으로 인한 심근외벽 파열김교희, 김태훈, 최영, 유영지pp. 234-238독사조신 복용 후 발생한 여성형유방증 1예박인성, 박치환, 박승운, 정준훈, 유진석, 이남희pp. 239-242말단비대증 환자에서 발생한 급성 림프구백혈병 1예최민석, 유순집, 신진경, 권희선, 오영승, 손장원, 김성래pp. 243-247
원문 보기